Skip to main content

Table 3 Cardiovascular, Fitness and Dietary Health Parameters Before and After the Cardio-Oncology Risk Reduction Program

From: Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy

Variable Baseline Follow-up P Value
Cardiovascular Clinical Evaluation
 Systolic BP/Diastolic BP (mm Hg) 136.7 ± 19.4 124.1 ± 14.0 0.001
 Diastolic Blood Pressure (mm Hg) 84 ± 12.9 78.7 ± 8.2 0.03
 Resting Heart Rate (beats per minute) 81 ± 12.9 86 ± 13.5 0.19
 Body Mass Index (kg/m2) 29.8 ± 9.8 31.5 ± 7.3 0.58
 Body Fat (%) 41.1 ± 5.8 41.3 ± 3.8 0.66
Cardiovascular Laboratory Evaluation
 Total Cholesterol (mg/dL) 183.1 ± 43.6 184.6 ± 45.0 0.40
 HDL Cholesterol (mg/dL) 55.1 ± 16.6 53.7 ± 14.7 0.34
 LDL Cholesterol (mg/dL) 100.6 ± 40.1 104.4 ± 44.9 0.20
 Triglycerides (mg/dL) 137.9 ± 71.6 155.4 ± 105 0.12
 Hemoglobin A1C (%) 7.4 ± 8.3 5.6 ± 0.8 0.11
Physical Fitness Evaluation
 Arm Curl Test (repetitions) 18.5 ± 4.5 21.8 ± 4.7 0.008
 Sit to Stand Test (repetitions) 12.8 ± 2.6 14.5 ± 2.9 0.05
 Trunk Flexion Test (repetitions) 13.6 ± 4.1 12.6 ± 3.2 0.80
Nutrition Evaluation
 REAP Score 26.6 ± 4.7 28.7 ± 4.7 0.007
  1. Values listed as means ± standard deviation; Bold indicates statistical significance; BP blood pressure, REAP Rapid Eating Assessment for Participants